Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Factors contributing to initial weight loss among adolescents with polycystic ovary syndrome.

Geier LM, Bekx MT, Connor EL.

J Pediatr Adolesc Gynecol. 2012 Dec;25(6):367-70. doi: 10.1016/j.jpag.2012.06.008. Epub 2012 Oct 22.

PMID:
23089571
2.

Differences in the management of adolescents with polycystic ovary syndrome across pediatric specialties.

Auble B, Elder D, Gross A, Hillman JB.

J Pediatr Adolesc Gynecol. 2013 Aug;26(4):234-8. doi: 10.1016/j.jpag.2013.03.007. Epub 2013 May 29.

PMID:
23726135
3.

Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome.

Bekx MT, Connor EC, Allen DB.

J Pediatr Adolesc Gynecol. 2010 Feb;23(1):7-10. doi: 10.1016/j.jpag.2009.04.004. Epub 2009 Aug 3.

PMID:
19648034
4.

Trends in standard workup performed by pediatric subspecialists for the diagnosis of adolescent polycystic ovary syndrome.

Powers SE, Uliassi NW, Sullivan SD, Tuchman LK, Mehra R, Gomez-Lobo V.

J Pediatr Adolesc Gynecol. 2015 Feb;28(1):43-6. doi: 10.1016/j.jpag.2014.03.002. Epub 2014 Mar 15.

PMID:
25555300
5.

Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.

Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ.

Hum Reprod Update. 2015 Sep-Oct;21(5):560-74. doi: 10.1093/humupd/dmv025. Epub 2015 Jun 9. Review.

PMID:
26060208
6.

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.

J Clin Endocrinol Metab. 2000 Aug;85(8):2767-74.

PMID:
10946879
8.

Dietary intake, eating behaviors, and quality of life in women with polycystic ovary syndrome who are trying to conceive.

Turner-McGrievy G, Davidson CR, Billings DL.

Hum Fertil (Camb). 2015 Mar;18(1):16-21. doi: 10.3109/14647273.2014.922704. Epub 2014 Jun 12.

PMID:
24921163
9.
10.

Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome.

Ornstein RM, Copperman NM, Jacobson MS.

J Pediatr Adolesc Gynecol. 2011 Jun;24(3):161-5. doi: 10.1016/j.jpag.2011.01.002. Epub 2011 Mar 21.

PMID:
21419674
11.

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.

Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH.

Hum Reprod. 2006 Jan;21(1):80-9. Epub 2005 Sep 30.

PMID:
16199429
12.

[Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition].

Le Donne M, Alibrandi A, Giarrusso R, Lo Monaco I, Muraca U.

Minerva Ginecol. 2012 Feb;64(1):23-9. Italian.

PMID:
22334228
13.

Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome.

Koiou E, Tziomalos K, Katsikis I, Kandaraki EA, Kalaitzakis E, Delkos D, Vosnakis C, Panidis D.

Gynecol Endocrinol. 2012 Jan;28(1):20-4. doi: 10.3109/09513590.2011.588745. Epub 2011 Jul 14.

PMID:
21756081
14.

Effect of Dietary Weight Loss on Menstrual Regularity in Obese Young Adult Women with Polycystic Ovary Syndrome.

Marzouk TM, Sayed Ahmed WA.

J Pediatr Adolesc Gynecol. 2015 Dec;28(6):457-61. doi: 10.1016/j.jpag.2015.01.002. Epub 2015 Jan 7.

PMID:
26298524
15.

Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses.

Harborne LR, Sattar N, Norman JE, Fleming R.

J Clin Endocrinol Metab. 2005 Aug;90(8):4593-8. Epub 2005 May 10.

PMID:
15886247
16.

Challenges and successes of a multidisciplinary pediatric obesity treatment program.

Walsh SM, Palmer W, Welsh JA, Vos MB.

Nutr Clin Pract. 2014 Dec;29(6):780-5. doi: 10.1177/0884533614551839. Epub 2014 Oct 21.

PMID:
25335786
17.

Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.

Ganie MA, Khurana ML, Nisar S, Shah PA, Shah ZA, Kulshrestha B, Gupta N, Zargar MA, Wani TA, Mudasir S, Mir FA, Taing S.

J Clin Endocrinol Metab. 2013 Sep;98(9):3599-607. doi: 10.1210/jc.2013-1040. Epub 2013 Jul 11.

PMID:
23846820
18.

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L.

Metabolism. 1999 Apr;48(4):511-9.

PMID:
10206447
19.

Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life.

Trent M, Austin SB, Rich M, Gordon CM.

Ambul Pediatr. 2005 Mar-Apr;5(2):107-11.

PMID:
15780012
20.

A comparison of bone mineral density in normal weight and obese adolescents with polycystic ovary syndrome.

To WW, Wong MW.

J Pediatr Adolesc Gynecol. 2012 Aug;25(4):248-53. doi: 10.1016/j.jpag.2011.12.073.

PMID:
22840935

Supplemental Content

Support Center